A Randomized, Multicenter, Single-Blind, Parallel-Group Phase III Non-Inferiority Trial Comparing the Efficacy and Tolerability of a Fixed-Dose Combination of Metronidazole, Bismuth Oxide and Tetracycline HCl to Standard Concomitant Non-Bismuth Quadruple Therapy for First-Line Eradication of Helicobacter pylori in Adults.
Not yet recruitingCTIS2026-525291-26-00
Verisfield Single Member S.A.Helicobacter Pylori Infection
Target: 420Updated: 2026-05-28